Finally, the [Cl−]o sensing site in CFTR that includes R899 on its extracellular face is a potential drug target for the correction of CF-causing gating mutants if a compound could be developed that mimicked the stimulatory effect of [Cl−]o on the channel. The gene discussed is CFTR; the disease is cystic fibrosis.